Asia-Pacific Duchenne Muscular Dystrophy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

SKU ID : GIR- 11685039

Publishing Date : 23-May-2018

No. of pages : 104

PRICE
4480
8960

  • Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

    Scope of the Report:
    This report focuses on the Duchenne Muscular Dystrophy in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

    Market Segment by Manufacturers, this report covers
    PTC Therapeutics
    Sarepta Therapeutics
    Bristol-Myers Squibb
    ITALFARMACO
    BioMarin
    Daiichi Sankyo
    Solid Biosciences
    Summit Therapeutics
    FibroGen
    NS Pharma
    Pfizer
    ReveraGen BioPharma
    Wave Life
    Genethon
    Santhera Pharmaceuticals

    Market Segment by Countries, covering
    China
    Japan
    Korea
    Taiwan
    Southeast Asia
    India
    Australia

    Market Segment by Type, covers
    Deflazacort
    Prednisone
    Others

    Market Segment by Applications, can be divided into
    Male
    Female

    There are 19 Chapters to deeply display the Asia-Pacific Duchenne Muscular Dystrophy market.

    Chapter 1, to describe Duchenne Muscular Dystrophy Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of Duchenne Muscular Dystrophy, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Duchenne Muscular Dystrophy, for each country, from 2013 to 2018;

    Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

    Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 Regin, with sales, revenue and market share by manufacturers, types and applications;

    Chapter 14, Duchenne Muscular Dystrophy market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

    Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

    Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

    Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

    Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports